baber/WOPTO huggingface dataset:
Patent IL-101148-A0 (IL)
Title: Lowering blood cholesterol levels using cellulose ethers
IPC: A23L1/308
Filed: 1992-03-05
Abstract: A method for reducing the cholesterol level in mammalian blood by administering a water soluble cellulose ether thereto. The cellulose ethers have a viscosity, measured as a 2% aqueous solution at 20 DEG C, of at least about 35 cps. Oral administration is preferred, and, in one embodiment the high viscosity water soluble cellulose ether is hydroxypropyl methylcellulose, contained in a nutritious foodstuff.
Patent IL-101647-A0 (IL)
Title: Chamber
IPC: A61G10/02
Filed: 1992-04-19
Abstract: A chamber suitable for placing a subject under a pressure greater than atmospheric pressure with means for perfusing, cooling and respiring the subject. The chamber can be used in conjuction with low temperature surgical procedures.
Patent IL-103409-A0 (IL)
Title: Method of subtitling motion picture film
IPC: G03C11/02
Filed: 1992-10-11
Abstract: The process for subtitling cinematographic films intended to apply graphic components, characters or texts to a cinematographic film with the aid of a laser beam running over the region to be marked on the film comprises the following two stages: in a first stage, a laser etching operation is carried out by virtue of the application of a laser beam whose speed of travel at the film is between approximately 1cm/s and 200cm/s and whose power at the film is between approximately 100 milliwatts and approximately 20 watts, the S/P ratio of the speed of travel expressed in cm/s to the power at the film, expressed in watts, being between 10 and 30 and sufficiently high for the laser beam to perform a complete conversion of the emulsion in the etched regions by causing a heating, a softening and a dislocation of the emulsion without effecting a complete removal of this converted emulsion; and, in a second stage, the etched film is subjected to a treatment for cleaning the etched regions, especially by placing the film in contact with a bath which ensures the removal, in the regions of the film which were previously marked by the low-power laser beam, of the particles of emulsion which have been heated and dislocated by the laser beam, thus allowing transparent subtitles to appear.
Patent IL-109297-A0 (IL)
Title: Process for the production of beta-alkoxy acrylic acid
IPC: C07C67/343
Filed: 1994-04-12
Abstract: PCT No. PCT/FR94/00418 Sec. 371 Date Oct. 3, 1995 Sec. 102(e) Date Oct. 3, 1995 PCT Filed Apr. 14, 1994 PCT Pub. No. WO94/24085 PCT Pub. Date Oct. 27, 1994A method for prerparing compounds of formula (I), wherein R is an optionally substituted alkenyl or alkynyl radical having up to 8 carbon atoms, or an optionally substituted mono- or polycyclic aryl or heteroaryl radical, and R1 and R2 are an alkyl radical having up to 4 carbon atoms. According to the method, a compound of the formula (II), wherein X is a halogen atom, is exposed to an organometallic compound of the formula (III): RZ, wherein R has the same meaning as before and Z is a metal or metal derivative. Alternatively, a compound of formula (II'), wherein Z' is a metal or metal derivative, is exposed to a compound of the formula (III'): RX', wherein X' is a nucleophilic reaction leaving group.    <IMAGE>  (I)   <IMAGE>  (II)   <IMAGE>  (II1)
Patent IL-114482-A0 (IL)
Title: Implanted tumor cells for the prevention and treatment of cancer
IPC: A61K38/19
Filed: 1995-07-06
Abstract: An implantable device for the prevention or treatment of cancer comprising an implantable chamber containing tumor cells, or somatic cells engineered to express at least one antigen corresponding to antigen of a patient's tumor; the chamber having a porous wall to provide, in use, a porous boundary between the patient's immune cells and the contained cells; the porosity of the boundary being sufficient to permit subcellular antigenic material to pass through the boundary, while preventing the contained cells and patient immune cells from passing through the boundary.
Patent IL-146459-A0 (IL)
Title: Previns as specific inhibitors and therapeutic agents for botulinum toxin b and tetanus neurotoxins
IPC: C12P21/02
Filed: 2000-05-15
Abstract: The compounds of the invention are generally described by the formula: <?in-line-formulae description="In-line Formulae" end="lead"?>B<SUB>1</SUB>Z*<SUB>2</SUB>B<SUB>3</SUB>Z*<SUB>4</SUB>X*<SUB>5</SUB>Q<SUB>6</SUB>F<SUB>7</SUB>X<SUB>8</SUB>X<SUB>9</SUB>X<SUB>10</SUB>X<SUB>11</SUB>, (1)<?in-line-formulae description="In-line Formulae" end="tail"?> <?in-line-formulae description="In-line Formulae" end="lead"?>B<SUB>1</SUB>X<SUB>2</SUB>X<SUB>3</SUB>X<SUB>4</SUB>X<SUB>5</SUB>Q<SUB>6</SUB>F<SUB>7</SUB>X<SUB>8</SUB>X<SUB>9</SUB>X<SUB>10</SUB>X<SUB>11</SUB>, or (2)<?in-line-formulae description="In-line Formulae" end="tail"?> <?in-line-formulae description="In-line Formulae" end="lead"?>B<SUB>1</SUB>Z<SUB>2</SUB>B<SUB>3</SUB>X<SUB>4</SUB>Z<SUB>5</SUB>Q<SUB>6</SUB>F<SUB>7</SUB>Z<SUB>8</SUB>X<SUB>9</SUB>X<SUB>10</SUB>X<SUB>11</SUB> (3)<?in-line-formulae description="In-line Formulae" end="tail"?> and the salts, esters, amides, and acyl forms thereof. Each position represented by a letter indicates a single amino acid residue: B is a basic of polar/large amino acid or a modified form thereof; X is a small or hydrophobic amino acid or a modified form thereof; X* is a small or polar/large amino acid or a modified form thereof; Z is a polar/large or hydrophobic amino acid or a modified form thereof; Z* is Proline or a polar/large of hydrophobic amino acid or a modified form thereof. As described below, one or more of the peptide linkages between the amino acid residues may be replaced by a peptide linkage mimic. These compounds may be used as molecular building blocks to create compounds that are optimized for inhibiting the protease activity of Botulinum b and tetanus toxins.
Patent IL-150420-A0 (IL)
Title: Pyrimidine and triazine kinase inhibitors
IPC: A61P1/00
Filed: 2000-12-22
Abstract: Compounds that selectively inhibit inappropriate kinase activities and methods for their preparation are disclosed. In one embodiment, the compounds are represented by Formula (I). As selective inhibitors of inappropriate kinase activities, the compounds of the present invention are useful in the treatment of conditions associated with such activity, including, but not limited to, inflammatory and autoimmune responses, diabetes, asthma, psoriasis, inflammatory bowel disease, transplantation rejection, and tumor metastasis. Also disclosed are methods of inhibiting inappropriate kinase activities and methods of treating conditions associated with such activities.
Patent IL-162842-A0 (IL)
Title: Indictor strip and a device for automatic testing of liquids
IPC: G01N33/18
Filed: 2004-07-04
Abstract: A continuous indicator strip having a multiplicity of separate individual sequential test sections along the surface thereof, wherein a plurality of test sections are impregnated with the same indicator enabling the utilization of the strip for sequential repetitive testing of samples, the strip being provided with at least 20 such test sections.
Patent IL-177944-A0 (IL)
Title: Needle and hub assembly for automatic injector
IPC: A61M5/32
Filed: 2006-09-07
Abstract: A needle and hub assembly for automatic injectors includes a cap or skirt that has a forward surface interposed between and reinforced by first and second engaged hub portions. A needle is received in a contiguous channel formed in the two hub portions. Methods of forming the assembly include molding the first hub portion, placing the cap over the first hub portion, inserting the needle into the channel in the first hub portion, and then overmolding or otherwise forming the second hub portion on the exterior of the first hub portion and cap such that the second hub portion engages the first hub portion. An assembly created by this “two-shot” process can be used to seal a relatively large opening in a medicament cartridge and to support the needle more effectively than a conventional assembly.
Patent IL-187678-A0 (IL)
Title: Agent for the prevention and treatment of liver diseases containing pyrazolopyrimidine derivative
Filed: 2007-11-27
Abstract: The present invention relates to the pharmaceutical composition for prevention and treatment of liver diseases containing pyrazolopyrimidine derivative as an active ingredient. According to the present invention, pyrazolopyrimidine derivative has an excellent effect on inhibiting collagen synthesis in hepatic stellate cells and acts directly on the portal vein. Particularly, it may increase the diameter and the amount of blood flow of the portal vein, and finally decrease the pressure thereof. Therefore, pyrazolopyrimidine derivative can be used advantageously for prevention and treatment of hepatic fibrosis, liver cirrhosis caused by hepatic fibrosis, portal hypertension and various complications caused by portal hypertension. In addition, pyrazolopyrimidine derivative according to the present invention can reduce dosing frequency because of its long half-life, and therefore, has an advantage to improve the drug compliance of patients suffering from chronical liver diseases.
Patent IL-205003-A0 (IL)
Title: Substituted n-phenyl-bipyrrolidine carboxamides and therapeutic use thereof
Filed: 2010-04-11
Abstract: The present invention discloses and claims a series of substituted N-phenyl-bipyrrolidine carboxamides of formula (I). Wherein R, R1, R2, R3 and R4 are as described herein. More specifically, the compounds of this invention are modulators of H3 receptors and are, therefore, useful as pharmaceutical agents, especially in the treatment and/or prevention of a variety of diseases modulated by H3 receptors including diseases associated with the central nervous system. Additionally, this invention also discloses methods of preparation of substituted N-phenyl-bipyrrolidine carboxamides and intermediates therefor.
Patent LU-86123-A1 (LU)
Inventor: LEGROS ALAIN
IPC: A23L3/00
Filed: 1985-10-17
Abstract: PCT No. PCT/BE86/00032 Sec. 371 Date Aug. 3, 1987 Sec. 102(e) Date Aug. 3, 1987 PCT Filed Oct. 14, 1986 PCT Pub. No. WO87/02221 PCT Pub. Date Apr. 23, 1987.Disinfectant composition and disinfection process for infected liquids or surfaces using, in addition to ions of at least one metal selected among copper, silver and manganese, a quaternary ammonium polymer or copolymer obtained by condensation of at least one difunctional tertiary amine with an organic halide.
Patent MA-22861-A1 (MA)
Inventor: KETIL HOX
IPC: C09C1/48
Filed: 1993-04-01
Abstract: PCT No. PCT/NO93/00058 Sec. 371 Date Dec. 22, 1994 Sec. 102(e) Date Dec. 22, 1994 PCT Filed Apr. 5, 1993 PCT Pub. No. WO93/20154 PCT Pub. Date Oct. 14, 1993.For producing carbon black material having a surface area of less than 5 m2/g, a dibutyl phthalate absorption of less than 30 ml/100 g and density compressed to 1.5-1.7 g/cm3 and a specific electrical resistance of less than 0.1 ohmcm for use as an anode material for aluminum production, a method includes a first stage delivering feedstock through a feed tube to a plasma torch to a reaction area to raise the temperature of the feedstock to about 1600 DEG  C., then passing the dehydrogenated carbon material to a second stage to complete the decomposition to carbon black and hydrogen; adding additional raw material to cause quenching and reaction with formed carbon black to increase particle size density and quantity produced.
Patent MA-28153-A1 (MA)
Title: Acides nucléiques se liant spécifiquement à la ghréline biologiquement active
Inventor: KLUSSMANN SVEN
IPC: C12Q1/68
Filed: 2006-05-10
Abstract: Acides nucléiques se liant spécifiquement à la ghréline biologiquetnent active La présente invention concerne un acide nucléique se liant spécifiquement, à la ghréline biologiquement active, plus avantageusement la n-octanoyl-ghréline, et son utilisation pour le diagnostic de maladies et affections à médiation par la ghréline.
Patent MA-38024-A1 (MA)
Title: Effet sedatif de l extrait alcaloidique et ethanoique des graines de delphinium staphysagia
Inventor: FARDI BOUCHRA
IPC: A61P25/20
Filed: 2015-04-21
Abstract: Effet sedatif de l extrait alcaloidique et ethanoique des graines de delphinium staphysagia
Patent MA-38056-A1 (MA)
Title: Inhibiteurs de la tyrosine kinase de bruton
Inventor: SPRINGER JOHN ROBERT
IPC: C07D401/04
Filed: 2013-11-01
Abstract: La présente invention concerne des composés qui forment des liaisons covalentes avec la tyrosine kinase de bruton (btk). L'invention concerne en outre des procédés de préparation des composés. L'invention concerne également des compositions pharmaceutiques qui comprennent les composés. L'invention concerne de plus des procédés d'utilisation des inhibiteurs btk, seuls ou en combinaison avec d'autres agents thérapeutiques, pour le traitement de maladies ou d'états auto-immuns, de maladies ou d'états hétéro-immuns, de cancer, comprenant le lymphome, et de maladies ou d'états inflammatoires. (formule i) (i)
Patent MA-39137-A1 (MA)
Title: Panneau de coffrage adapte a la retenue d'une matrice de remplissage.
Inventor: DURAND PHILIPPE
IPC: E04G21/18
Filed: 2014-12-18
Abstract: Panneau (1) de coffrage, caractérisé en ce qu'il comprend des orifices filtrants (4) traversant entre une face intérieure dudit panneau (1), destinée au coffrage d'un matériau de remplissage, et une face extérieure dudit panneau, chaque orifice (4) ayant une section allant en se rétrécissant progressivement en allant de ladite face intérieure vers ladite face extérieure.
Patent MA-42348-A1 (MA)
Title: Preparation alimentaire naturelle ayant un indice glycemique bas
Inventor: IBRAHIMI ILHAM
IPC: A21D13/40
Filed: 2018-05-04
Abstract: La présente invention concerne une préparation diététique alimentaire naturelle à vertus thérapeutiques et à indice glycémique bas, présentant un intérêt nutritionnel universel intéressant pour tous les régimes : cétogène lié à l’épilepsie résistante aux médicaments, végétarien et sans gluten. La préparation alimentaire diététique selon l’invention comprend le mélange des ingrédients suivants :- 28 à 37% de pulpe de figue de barbarie déshydratée - 15 à 25% de flocons d’avoine - 10 à 20% de graines de sésame - 13 à 23% d’amandes concassées - 1 à 5% graines de courges - 1 à 5% graines de tournesol - 1 à 5% poudre d’anis
Patent MA-51359-A1 (MA)
Title: Nouveau procédé de coagulation du lait camelin arganier, fermenté et amélioré par des extraits de souches probiotiquesautochtones
Inventor: FOUZIA ZKHIRI
IPC: A23L33/135
Filed: 2020-10-01
Abstract: Cette invention consiste en un nouveau process de valorisation du lait camelin marocain, considéré comme une très bonne source de minéraux, d’antioxydants et d’acides gras nécessaires pour les consommateurs,lié à des concentrations élevées de lysozyme, de lactoperoxydase, de lactoferrine et de bactériocines produites par ses bactéries lactiques autochtones.Cependant, le lait camelin se distingue par une composition différente de celle du lait bovin, principalement en formulation protéique, ce qui rend sa transformation en produits fromagers difficile à cause de sa stabilité thermique et son taux de coagulation qui sont faibles.
Patent UY-27337-A1 (UY)
Title: Derivados aromáticos de ácidos dicarboxílicos
Inventor: ZIMMERMANN GERD
Filed: 2002-06-14
Abstract: Compuesto de fórmula I en donde A, R1, Y R2, tienen los significados definidos en la especificación, procedimiento de preparación de estos compuestos y medicamentos con actividad inhibidora de la HADAC que contiene dicho compuesto.
Patent UY-27850-A1 (UY)
Title: Nuevos carbamatos de quinuclidina y composiciones farmacéuticas que los contienen
Inventor: QUINONES MARIA PRAT
IPC: A61P25/00
Filed: 2003-06-16
Abstract: Derivados de carbamato de quinuclidina carbamatos de fórmula o sus sales farmacéuticamente aceptables, incluyendo las sales de amonio cuaternario de fórmula (II) así como procedimientos para su preparación, las composiciones farmacéuticas que los contienen y su uso en terapia como antagonistas de receptores muscarínicos M3.
Patent UY-29912-A1 (UY)
Title: Mezclas fungicidas, que contienen boscalida y pirimetanilo
Inventor: EVAN DR GOLD RANDALL
IPC: A01N25/00
Filed: 2006-11-10
Abstract: Mezclas fungicidas, que contienen boscalida de la fórmula (I) y pirimetanilo de la fórmula (II) en una cantidad sinergéticamente efectiva, procedimiento para combatir hongos nocivos con mezclas de boscalida (I) y pirimetanilo (II) y el uso de boscalida (I) y pirimetanilo (II) para la obtención de tales mezclas, productos, que contienen estas mezclas, así como semillas, que contienen estas mezclas.
Patent UY-30265-A1 (UY)
Title: Inhalador
Inventor: BOECK DR GEORG
IPC: B65D83/06
Filed: 2007-04-10
Abstract: Un inhalador para administrar un medicamento en forma de sustancias inhalables, formulaciones o mezclas de sustancia comprende una carcasa (1) que presenta un interior para alojar el medicamento, que está acoplada con una boquilla (2). La carcasa (1) está unida de forma fija con la boquilla (2).
Patent UY-31039-A1 (UY)
Title: Derivados de quinolina-carboxamida en calidad de antagonistas de p2y12
Inventor: CZECH JOERG DR
IPC: A61P7/02
Filed: 2008-04-21
Abstract: Compuestos derivados de quinolina-carboxamida en calidad de antagonistas de P2Y12 de formula I, en la que R1, R2, R3, R4, R5, R6, Z; A; B; E; X; Q; J; V; G; y M tienen los significados indicados en las reivindicaciones. Exhiben efecto anti-agregante sobre plaquetas y, así, un efecto anti-trombotico. Son antagonistas reversibles del receptor de ADP de plaquetas P2Y12. La invencion se refiere además a procedimientos para preparar compuestos de formula I, a su uso como ingredientes activos en productos farmacéuticos, y a preparaciones farmacéuticas que los contienen.
Patent UY-31494-A1 (UY)
Title: Formulaciones de soluciones oftalmicas u opticas para uso topico que contienen clorhidrato de moxifloxacina y fosfato de dexametasona
Inventor: PH D
IPC: A61K9/08
Filed: 2008-11-27
Abstract: Se describen composiciones de soluciones oftálmicas y opticas moxifloxacina y fosfato de dexametasona para administracion topica.
Patent CS-654986-A1 (CS)
Title: Distinguishable method for strange bodies in agricultural machines harvesters
Inventor: WEISS BURKHARD DIPL ING
IPC: A01D75/18
Filed: 1986-09-11
Abstract: A hard foreign body in a stream of cut crop being moved by a conveyor in an agricultural machine to a crop comminuter of the machine is detected by first compressing the stream of cut crop transversely of its displacement direction between a pair of feed elements one of which is movable toward and away from the other and generating an actual-value output corresponding to the acceleration of the movable element toward and away from the other element. This output is compared with a set point corresponding to an acceleration level not normally exceeded by the element when the crop stream contains no hard foreign objects. An error signal is generated when the actual-value output exceeds the set point. When the error signal is issued advance of the conveyor is stopped and/or a warning is issued. The actual-value output is only generated when the acceleration of the movable feed element exceeds a predetermined limit. The actual-value output is a voltage and the set point is also a voltage.
Patent ES-176603-A1 (ES)
Title: Mejoras en o relativas a terminaciones para cables eléctricos
Filed: 1947-01-30
Abstract: Terminación para un cable eléctrico que comprende un buje de cerámica provisto con una abertura o aberturas que pueden ser selladas para el uso del conductor o conductores y que tiene aquellas partes de la superficie del mismo con las que se ha de hacer contacto metálico metalizadas junto con un cuerpo metálico soldado a dicha superficie metalizada y conectado en forma hermética a la cubierta del cable.
Patent ES-177863-A1 (ES)
Title: MEJORAS EN O RELATIVAS A APARATOS DE DESCARGA ELECTRoNICA
IPC: H01J25/08
Filed: 1947-05-03
Abstract: Aparatos de descarga electrónica del tipo a que se ha hecho referencia caracterizados en que la parte interior del resonador (tubo de arrastre) está constituido por una estampación de lámina de metal que tiene forma para proveer la ranura a través de la cual están adaptados para pasar los electrones.
Patent ES-180824-A1 (ES)
Title: UN PROCEDIMIENTO Y DISPOSITIVO PARA LA CONCENTRACIoN DE LiQUIDOS
Filed: 1947-12-10
Abstract: Procedimiento para la concentración de líquidos por medio de superficies calentadoras, consistente en imprimir el líquido que se desea concentrar un rápido movimiento de rotación por la acción de las superficies calentadoras.
Patent ES-187020-A1 (ES)
Title: UN PROCEDIMIENTO PARA LA PREPARACIoN DE ANTIBIoTICOS
Filed: 1949-02-12
Abstract: Procedimiento que comprende someter una raza de A. griseus resistente a la estreptomicina a la acción de un agente transformador en condiciones tales que la mayoría de las esporas se mueran sembrar las esporas sobrevivientes en placas de agar nutritivo transferir colonias de actinomicetos desarrollados en agar nutritivo a tubos de ensayo inclinados de agar para la esporulación propagar las esporas así desarrolladas en agentes nutritivos separados durante unos 3-4 días y ensayar los agentes fermentados en cuanto al contenido de estreptomicina; seleccionar una raza que ofrece un rendimiento de estreptomicina; seleccionar una raza que ofrece un rendimiento de estreptomicina por lo menos de 40-50% más alto que la raza madre resistente y repetir el tratamiento con un agente mutante siguiendo a esto la siembra esporulación propagación ensayo y selección para desarrollar las razas de A. griseus transformadas de rendimiento más alto para desarrollarlas hasta que se obtiene una mutante que constantemente ha de producir por lo menos 800 microgramos/ml de estreptomicina al propagarse en un agente nutritivo con condiciones de aireación sumergida.
Patent ES-187370-A1 (ES)
Title: Un procedimiento de preparar sales de piridinio
Filed: 1949-03-08
Abstract: Procedimiento de preparar sales cuaternarias de piridino de compuestos que tiene la fórmula estructural I que comprende hacer reaccionar un 3-piridol con un haluro carbamílico que tiene la fórmula estructural II y con un compuesto cuaternizante.
Patent ES-192502-A1 (ES)
Title: PROCEDIMIENTO Y APARATO PARA LA PRODUCCIoN CONTINUA DE ALDOL
Filed: 1950-04-13
Abstract: Procedimiento continuo de producción de aldol en dos fases a partir de acetaldehido en presencia de reactivo de aldolización y a una temperatura más elevada en la primera fase que en la segunda procedimiento caracterizado por el hecho de que se mantiene una mezcla líquida de acetaldehido de aldol y de reactivo de aldolización primeramente a una temperatura elevada y bajo una presión que impide la ebullición a esta temperatura durante un breve lapso de tiempo que no exceda de 1 minuto manteniendo siempre esta temperatura sensiblemente constante y seguidamente a una temperatura menor durante un lapso mayor que el primero de manera que pueda seguir la reacción de aldolización.
Patent ES-196039-A1 (ES)
Title: PROCEDIMIENTO Y DISPOSITIVO PARA LA FABRICACIoN DE GANDES ELEMENTOS DE CONSTRUCCIoN.
Filed: 1951-01-05
Abstract: Procedimiento para la fabricación ae grandes elementos de construcción para la producción de paredes de edificios de varias capas con altura de un piso por ejemplo para casas de habitación caracterizado porque en una vagoneta de hormigonado de varios ejes se ejecuta el proceso de producción en ambas direcciones de marcha sin dar vuelta al instrumento.